Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence

Completed · Phase 2 · Has a placebo group

Conditions studied: Depressive Disorder, Major, Cannabis Abuse

In brief

Adolescents who are diagnosed with major depressive disorder are often also diagnosed with marijuana dependence. Fluoxetine is an antidepressant medication currently used to treat young people who are diagnosed with major depressive disorder. The purpose of this study is to determine the effectiveness of fluoxetine in treating adolescents and young adults diagnosed with both major depressive disorder and marijuana dependence.

Key facts

Study ID
NCT00149643
Run by
University of Pittsburgh
People needed
70
Starts
2004-09-01
Expected to finish
2012-12-01
Last updated by the study team
2013-06-24

Who can join

Age: 14 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.